Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Galantamine Augmentation of Escitalopram in Depression
NCT00423969Phase 4Terminated
- Sponsor
- Indiana University School of Medicine
- Start
- Nov 2003
- Modality
- Nucleic Acid-Directed Small Molecules, Classical Binding Small Molecules, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 4 trial of galantamine in major depressive disorder (MDD), sponsored by Indiana University School of Medicine. Started Nov 2003; status: terminated.
02
Drugs
galantamine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00423969.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00423969.